TechnoRep - Faculty of Technology and Metallurgy Repository
University of Belgrade - Faculty of Technology and Metallurgy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   TechnoRep
  • Tehnološko-metalurški fakultet
  • Radovi istraživača / Researchers’ publications (TMF)
  • View Item
  •   TechnoRep
  • Tehnološko-metalurški fakultet
  • Radovi istraživača / Researchers’ publications (TMF)
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Innovative and generic pharmaceuticals industry and drugs market

Inovativna i generička farmaceutska industrija i tržište lekova

No Thumbnail
Authors
Jovanović, Slobodanka
Matović, Danijela
Petrović, Slobodan
Article (Published version)
Metadata
Show full item record
Abstract
The pharmaceutical industry consists of two sectors: the innovative sector and generic sector. The innovative pharmaceutical industry is totally dependent on patents and these companies are focused on protecting against commodity and branded generics. Global pharmaceutical markets have experienced dramatic changes in recent years. The current global financial crisis is likely to hit pharmaceutical companies due to a lack of funding for research and production of many new drugs , while the national governments, concerned with the rising cost of pharmaceuticals within their national healthcare budgets, are striving to promote the use of generics over high-priced originator products. Serbia has the innovative generic pharmaceutical industry. .
Farmaceutsku industriju sačinjavaju dva sektora: inovativni i generički sektor. Inovativna farmaceutska industrija je u potpunosti zavisna od patenata i ove kompanije su fokusirane na zaštitu od generika (zaštićenih ili nezaštićenih žigom). Svetsko farmaceutsko tržište je pretrpelo dramatične promene poslednjih godina. Tekuća svetska finansijska kriza je izgleda pogodila farmaceutske kompanije zbog nedostatka fondova za istraživanje i proizvodnju mnogih novih lekova, dok nacionalne vlade obzirom na povećanje troškova lekova u okviru nacionalnog zdravstvenog budžeta, nastoje da promovišu generike u odnosu na skuplje originalne proizvode. Srbija ima inovativno - generičku industriju.
Keywords:
medicine / innovative / generic / industry / financial crisis / lek / inovativna / generička / industrija / finansijska kriza
Source:
Industrija, 2010, 38, 1, 105-119
Publisher:
  • Economics institute, Belgrade

ISSN: 0350-0373

[ Google Scholar ]
Handle
https://hdl.handle.net/21.15107/rcub_technorep_1580
URI
http://TechnoRep.tmf.bg.ac.rs/handle/123456789/1580
Collections
  • Radovi istraživača / Researchers’ publications (TMF)
Institution/Community
Tehnološko-metalurški fakultet
TY  - JOUR
AU  - Jovanović, Slobodanka
AU  - Matović, Danijela
AU  - Petrović, Slobodan
PY  - 2010
UR  - http://TechnoRep.tmf.bg.ac.rs/handle/123456789/1580
AB  - The pharmaceutical industry consists of two sectors: the innovative sector and generic sector. The innovative pharmaceutical industry is totally dependent on patents and these companies are focused on protecting against commodity and branded generics. Global pharmaceutical markets have experienced dramatic changes in recent years. The current global financial crisis is likely to hit pharmaceutical companies due to a lack of funding for research and production of many new drugs , while the national governments, concerned with the rising cost of pharmaceuticals within their national healthcare budgets, are striving to promote the use of generics over high-priced originator products. Serbia has the innovative generic pharmaceutical industry. .
AB  - Farmaceutsku industriju sačinjavaju dva sektora: inovativni i generički sektor. Inovativna farmaceutska industrija je u potpunosti zavisna od patenata i ove kompanije su fokusirane na zaštitu od generika (zaštićenih ili nezaštićenih žigom). Svetsko farmaceutsko tržište je pretrpelo dramatične promene poslednjih godina. Tekuća svetska finansijska kriza je izgleda pogodila farmaceutske kompanije zbog nedostatka fondova za istraživanje i proizvodnju mnogih novih lekova, dok nacionalne vlade obzirom na povećanje troškova lekova u okviru nacionalnog zdravstvenog budžeta, nastoje da promovišu generike u odnosu na skuplje originalne proizvode. Srbija ima inovativno - generičku industriju.
PB  - Economics institute, Belgrade
T2  - Industrija
T1  - Innovative and generic pharmaceuticals industry and drugs market
T1  - Inovativna i generička farmaceutska industrija i tržište lekova
EP  - 119
IS  - 1
SP  - 105
VL  - 38
UR  - https://hdl.handle.net/21.15107/rcub_technorep_1580
ER  - 
@article{
author = "Jovanović, Slobodanka and Matović, Danijela and Petrović, Slobodan",
year = "2010",
abstract = "The pharmaceutical industry consists of two sectors: the innovative sector and generic sector. The innovative pharmaceutical industry is totally dependent on patents and these companies are focused on protecting against commodity and branded generics. Global pharmaceutical markets have experienced dramatic changes in recent years. The current global financial crisis is likely to hit pharmaceutical companies due to a lack of funding for research and production of many new drugs , while the national governments, concerned with the rising cost of pharmaceuticals within their national healthcare budgets, are striving to promote the use of generics over high-priced originator products. Serbia has the innovative generic pharmaceutical industry. ., Farmaceutsku industriju sačinjavaju dva sektora: inovativni i generički sektor. Inovativna farmaceutska industrija je u potpunosti zavisna od patenata i ove kompanije su fokusirane na zaštitu od generika (zaštićenih ili nezaštićenih žigom). Svetsko farmaceutsko tržište je pretrpelo dramatične promene poslednjih godina. Tekuća svetska finansijska kriza je izgleda pogodila farmaceutske kompanije zbog nedostatka fondova za istraživanje i proizvodnju mnogih novih lekova, dok nacionalne vlade obzirom na povećanje troškova lekova u okviru nacionalnog zdravstvenog budžeta, nastoje da promovišu generike u odnosu na skuplje originalne proizvode. Srbija ima inovativno - generičku industriju.",
publisher = "Economics institute, Belgrade",
journal = "Industrija",
title = "Innovative and generic pharmaceuticals industry and drugs market, Inovativna i generička farmaceutska industrija i tržište lekova",
pages = "119-105",
number = "1",
volume = "38",
url = "https://hdl.handle.net/21.15107/rcub_technorep_1580"
}
Jovanović, S., Matović, D.,& Petrović, S.. (2010). Innovative and generic pharmaceuticals industry and drugs market. in Industrija
Economics institute, Belgrade., 38(1), 105-119.
https://hdl.handle.net/21.15107/rcub_technorep_1580
Jovanović S, Matović D, Petrović S. Innovative and generic pharmaceuticals industry and drugs market. in Industrija. 2010;38(1):105-119.
https://hdl.handle.net/21.15107/rcub_technorep_1580 .
Jovanović, Slobodanka, Matović, Danijela, Petrović, Slobodan, "Innovative and generic pharmaceuticals industry and drugs market" in Industrija, 38, no. 1 (2010):105-119,
https://hdl.handle.net/21.15107/rcub_technorep_1580 .

DSpace software copyright © 2002-2015  DuraSpace
About TechnoRep | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceInstitutions/communitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About TechnoRep | Send Feedback

OpenAIRERCUB